Form 8-K - Current report:
SEC Accession No. 0001437749-25-013232
Filing Date
2025-04-28
Accepted
2025-04-28 08:00:33
Documents
14
Period of Report
2025-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20250426_8k.htm   iXBRL 8-K 27173
  Complete submission text file 0001437749-25-013232.txt   169725

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20250424.xsd EX-101.SCH 3580
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20250424_def.xml EX-101.DEF 11808
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20250424_lab.xml EX-101.LAB 15859
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20250424_pre.xml EX-101.PRE 12023
16 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20250426_8k_htm.xml XML 2942
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 25875991
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)